EGCG prevents obesity-induced precocious puberty by reshaping lipid metabolism, with key enzymes (PISD, PLD, and PTDSS) in glycerophospholipid metabolism serving as potential therapeutic targets. This evidence concerns the gene PISD and obesity due to melanocortin 4 receptor deficiency.